Skip to content
lifestyle.easyhouseremodeling.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
https://immatics.com/
Immatics Presents Clinical Activity of IMA402 PRAME Bispecific and IMA203CD8 PRAME Cell Therapy across Advanced Solid Tumors in Two Oral Presentations at 2026 ESMO Annual Meeting
October 24, 2026
Immatics Announces $150 Million Underwritten Offering
August 25, 2026
Immatics Announces Second Quarter 2026 Financial Results and Business Update
August 18, 2026
Immatics Announces Upcoming Presentations Across Its PRAME Franchise at ESMO Congress 2026
July 17, 2026
Immatics Announces First Quarter 2026 Financial Results and Business Update
May 12, 2026